On April 25th, 2023, FDA is hosting a virtual public meeting on Patient-Focused Drug Development (PFDD) for Long Covid. This meeting will provide FDA the opportunity to obtain initial patient and patient representative input on the aspects of Long Covid, including how Long COVID affects their daily life, the symptoms that matter most to patients, their current approaches to treating Long Covid, and what they consider when determining whether or not to participate in a clinical trial.
Ahead of the FDA’s PFDD for Long Covid, Solve M.E. will host a webinar on March 30th from 11- 12 pm PT / 2-3pm ET to help educate our community about this important event.
This is a unique opportunity to share stories of living with Long Covid, as well as experiences with treatments, with important decision-makers at the FDA. Though Solve is not involved in the planning of the PFDD meeting, we have invited two former FDA officials who are experts in this area to help prepare our community for this important day.
The hoped outcome of the meeting is to improve the development of new drugs in the research pipeline and inform the context in which regulatory decisions will be made for new drugs for Long Covid.
During the webinar on March 30th, we will be covering the following topics:
It doesn’t matter where you live or where you are in your journey, what matters is your story.
Register here.
350 N Glendale Ave.
Suite B #368
Glendale, CA 91206
SolveCFS@SolveCFS.org
704-364-0016
EIN: 56-1683450
